Eyebright Medical(SH:688050) Zheng Quan Zhi Xing·2025-09-04 16:18Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by major shareholder Bai Ying, who reduced her stake in Aibo Medical from 4.95% to 2.95% through a series of block trades, totaling 3,862,700 shares, which represents 1.9972% of the company's total share capital [1][2]. Group 1: Shareholder Information - Bai Ying held 9,562,746 shares before the reduction, accounting for 4.95% of the total share capital [1]. - Bai Ying and her spouse, Mao Liping, are considered concerted actors, holding a combined total of 15,167,159 shares, which is 7.85% of the total shares [1][2]. Group 2: Reduction Plan Implementation - The reduction plan was first disclosed on June 4, 2025, and was executed between July 22 and September 3, 2025 [1]. - The shares were sold at prices ranging from 65.72 to 74.64 yuan per share, resulting in a total transaction amount of 276,823,762 yuan [1]. - The reduction was completed with only 62 shares remaining unsold, confirming that the plan was fully executed [1][2]. Group 3: Impact of the Reduction - The reduction does not trigger a mandatory tender offer, and the control structure of the company remains unchanged [1][2]. - Following the reduction, Bai Ying's shareholding decreased to 5,700,046 shares, or 2.95% of the total shares [1].